SEGALL BRYANT & HAMILL, LLC

Position in AMPH — Amphastar Pharmaceuticals, Inc.

CIK 1006378 CHICAGO, IL

Position in AMPH

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$672,357

+$19,658 QoQ

Shares Held

33,318

0.0% QoQ

Ownership

0.078%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#78

of 209 holders

Holding Since

Sep 2024

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

SEGALL BRYANT & HAMILL, LLC holds $61,046,740 across 14 Drug Manufacturers - Specialty & Generic names. AMPH ranks #14 (1.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALKS	Alkermes plc.	498,222	$26,106,832
2	NBIX	Neurocrine Biosciences Inc	64,908	$10,939,594
3	KNSA	Kiniksa Pharmaceuticals International, plc	71,901	$4,598,068
4	AMRX	Amneal Pharmaceuticals, Inc.	240,060	$4,155,438
5	LQDA	Liquidia Corp	50,802	$4,050,443
6	ANIP	Ani Pharmaceuticals Inc	32,860	$2,720,150
7	IRWD	Ironwood Pharmaceuticals Inc	408,064	$1,717,949
8	SUPN	Supernus Pharmaceuticals, Inc.	25,931	$1,206,050

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$672,357	33,318	0.0%	Shares	Sole	2026-08-12
2026-03-31	$652,699	33,318	+197.9%	Shares	Sole	2026-05-22
2025-12-31	$299,534	11,185	0.0%	Shares	Sole	2026-02-13
2025-09-30	$298,080	11,185	0.0%	Shares	Sole	2025-11-12
2025-06-30	$256,807	11,185	0.0%	Shares	Sole	2025-08-12
2025-03-31	$324,253	11,185	-40.8%	Shares	Sole	2025-05-02
2024-12-31	$701,051	18,881	-0.5%	Shares	Sole	2025-02-11
2024-09-30	$920,517	18,968	—	Shares	Sole	2024-11-08
No filing history on record for this holder in this stock.